Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

In the clinical trials of the quadrivalent human papillomavirus (qHPV) vaccine, antibodies were measured by a competitive Luminex immunoassay (HPV-4 cLIA). A nine-valent HPV (9vHPV) vaccine targeting the types in the qHPV vaccine (HPV6/11/16/18), as well as 5 of the next most frequent HPV types foun...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hum Vaccin Immunother
Main Authors: Roberts, Christine, Green, Tina, Hess, Erica, Matys, Katie, Brown, Martha J, Haupt, Richard M, Luxembourg, Alain, Vuocolo, Scott, Saah, Alfred, Antonello, Joseph
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2014
Teme:
Short Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896759/
https://ncbi.nlm.nih.gov/pubmed/25424920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29205
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki